Drupal.behaviors.print = function(context) {window.print();window.close();}>
Arrowhead Chief Sees Little Cost Increase Associated with Newly Acquired Peptide Tech
April 19, 2012
Arrowhead Chief Sees Little Cost Increase Associated with Newly Acquired Peptide Tech
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Arrowhead Picks Up Drug-Delivery Technology through Alvos Acquisition
April 12, 2012 / Gene Silencing News
Arrowhead Publishes Rodent, Primate Data on Preclinical Hepatitis B Therapy
February 28, 2013 / Gene Silencing News
Arrowhead Offers Timeline for HBV Candidate, Plans Two Phase I Trials
February 14, 2013 / Gene Silencing News
Arrowhead Publishes Primate Data on Co-Delivery Approach for Cholesterol-Conjugated siRNAs
November 29, 2012 / Gene Silencing News
Arrowhead Presents Preclinical Data on HBV Candidate, Subcutaneous Delivery Tech
November 8, 2012 / Gene Silencing News